Mullerian Mixed Tumor

A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p1703)

Also Known As:

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Endometrial Neoplasms (Endometrial Cancer)
2.	Ovarian Diseases (Ovarian Disease)
3.	Carcinosarcoma
4.	Papillary Carcinoma
5.	Mucinous Adenocarcinoma (Mucinous Carcinoma)

Experts

1.	Kreuzwieser, E: 1 article (04/2000)
2.	Rudenstam, G: 1 article (04/2000)
3.	Schmidt, D: 1 article (04/2000)
4.	Dallenbach-Hellweg, G: 1 article (04/2000)
5.	Granberg, S: 1 article (04/2000)
6.	Bourne, T: 1 article (04/2000)
7.	Dören, M: 1 article (04/2000)
8.	Hellberg, P: 1 article (04/2000)
9.	Rydh, W: 1 article (04/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Mullerian Mixed Tumor:

1.	TamoxifenFDA LinkGeneric 04/01/2000 - "None of the 19 endometrial neoplasms after tamoxifen therapy was of the endometrioid type: 11 were mucinous adenocarcinomas, 4 clear cell carcinomas, 2 serous-papillary carcinomas, one carcinosarcoma and one malignant Mullerian mixed tumor. "
2.	Estrone (Folliculin)FDA Link 06/01/1985 - "Polycystic ovarian disease, a condition characterized by unopposed estrinism due to the peripheral conversion of excessive androstenedione to estrone, was found in a 27-year-old infertile woman with an endometrial malignant mullerian mixed tumor. "
3.	Androstenedione (4 Androstene 3,17 dione)IBA 06/01/1985 - "Polycystic ovarian disease, a condition characterized by unopposed estrinism due to the peripheral conversion of excessive androstenedione to estrone, was found in a 27-year-old infertile woman with an endometrial malignant mullerian mixed tumor. "